When DL-Based Prescreening Meets Synthon-Based Docking: Target-Adapting PharmacoNet via MEL-Steered Correction
Liu, W.; Hong, Y.; Ku, T.; Lee, W.; Nguyen, E.; Xu, A.; Katritch, V.
Show abstract
As chemical libraries expand into the trillions of molecules, Virtual SYNthon Hierarchical Enumeration Screening (V-SYNTHES) has emerged as a leading strategy for making gigascale virtual screening computationally tractable. In V-SYNTHES, a Minimal Enumeration Library (MEL) of chemical fragments is docked against a target first, and only the top-scoring fragments are expanded into full ligands for large-scale docking. However, among the large number of comparably well-docked fragments, only a small fraction can be expanded under a fixed docking budget, leaving most similarly promising fragments unexplored. General-purpose prescreening tools can be adopted to address this constraint, reallocating the same docking budget across a larger pool of fragments' enumerated full ligands by their proxy score. However, such tools are applied without accounting for target-specific pocket environments. One such method, PharmacoNet, predicts interaction hotspots from a protein structure and ranks candidates via graph matching against a fixed set of interaction-type weights. We recognize that V-SYNTHES's initial fragment-docking step, ordinarily used only for selection of best fragments for expansion, already reveals which of these hotspots and interaction types a given pocket actually favors, and we can recover this signal to fine-tune PharmacoNet accordingly. We introduce MEL-Steered PharmacoNet, a parameter-efficient adaptation framework that specializes PharmacoNet to a given target through two composable mechanisms: (i) empirical density-map steering of predicted pharmacophore hotspots, and (ii) empirical fine-tuning of interaction-type scoring weights. Across three structurally distinct GPCR targets (CB2, GPR91, 5-HT2AR), MEL-Steered PharmacoNet achieves substantial enrichment factor (EF100) gains over a random baseline, and improves EF100 over PharmacoNet by 8.94x, 6.87x, and 1.69x, respectively. The fitted per-target weights further reveal distinct, chemically interpretable interaction profiles that PharmacoNet's generic fixed weights fail to capture. These results show that fragment-docking data already generated by the standard V-SYNTHES pipeline can adapt a general-purpose pharmacophore prescreening method to an individual target, significantly improving its performance while retaining its ultra-fast screening ability, with no additional experimental data or model retraining.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Rational Discovery of Dual-Action Multi-Target Kinase Inhibitor for Precision Anti-Cancer Therapy Using Structural Systems Pharmacology 94%
- Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with Deep Graph Networks 92%
- A novel transformer-based platform for the prediction and design of biosynthetic gene clusters for (un)natural products 92%
Similar papers in this journal
- Enhanced compound-protein binding affinity prediction by representing protein multimodal information via a coevolutionary strategy 93%
- InversePep: Diffusion-Driven Structure-Based Inverse Folding for Functional Peptides 93%
- ProDualNet: Dual-Target Protein Sequence Design Method Based on Protein Language Model and Structure Model 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.